TUBB8B
Tubulin beta 8B
As of the edition of 20 October 2026, TUBB8B (tubulin beta 8B, UniProt A6NNZ2) has 1 drug tested at it and 1 company on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- A6NNZ2
- How well studied
- Little studied
- Where it sits in the cell
- Inside the cell
- Disease areas
- Cancer; Urinary and reproductive; Blood and lymph; Digestive system; Lungs and airways; Pregnancy and women's health; Eye; Hormones
- Registered trials of its drugs
- 10
Drugs at this target
| Status | Count |
|---|---|
| Went quiet | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| ABT-751 | Went quiet | Phase 2 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 1 |
| Total on the list | 1 |